Medicine & Life Sciences
Opioid Receptors
100%
Buprenorphine
81%
Opioid Analgesics
68%
Narcotic Antagonists
61%
Ligands
61%
mu Opioid Receptor
50%
methocinnamox
48%
nociceptin
46%
nociceptin receptor
42%
kappa Opioid Receptor
42%
Naltrexone
40%
Peptide Receptors
33%
2-(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole
33%
Imidazolines
31%
2-(N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl)-3,3-dimethylpentan-2-ol
30%
RGS Proteins
23%
Morphine
22%
thevinone
22%
Binding Sites
20%
Cocaine
19%
Macaca mulatta
18%
Ethers
18%
clocinnamox
17%
Opioid Peptides
17%
Antidepressive Agents
16%
BU 224
15%
BU08070
14%
GTP-Binding Protein Regulators
14%
Pharmacology
14%
Opioid-Related Disorders
13%
In Vitro Techniques
13%
Primates
12%
Self Administration
12%
Brain
12%
Analgesics
12%
naltrindole
11%
2-(2-benzofuranyl)-2-imidazoline
10%
Imidazoline Receptors
10%
rimcazole
10%
morphinone
10%
Naloxone
10%
Substance-Related Disorders
10%
Haplorhini
10%
Heroin
10%
Morphinans
9%
carbazole
9%
6-codeinone
9%
Therapeutics
9%
Carbon-11
9%
4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide
9%
Chemical Compounds
Antagonist
31%
Narcotic Antagonist
30%
Buprenorphine
27%
Synthetic Cannabinoid
21%
Partial Agonist
19%
Agonist
19%
Ligand
19%
Morphinone
18%
Cannabinoid Receptor Agonist
15%
Nociceptin
14%
Agent Interacting With Transmitter, Hormone or Drug Receptor
14%
Imidazoline
11%
Codeinone
10%
Antinociceptive
10%
Kappa Opiate Receptor Antagonist
10%
Positron
9%
Morphinan
9%
Naltrexone
8%
Receptor Binding Affinity
7%
Ether
7%
Oripavine
7%
Drug
7%
Dopamine
6%
Monoamine
6%
Naloxone
6%
Cocaine
5%
Oxymorphone
5%
Naltrexone Hydrochloride
5%
Dihydroorotic Acid
5%
Binding Site
5%
Analgesic
5%
